# MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy

> **NCT03570918** · PHASE1 · COMPLETED · sponsor: **MacroGenics** · enrollment: 21 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **BIOLOGICAL:** MGD014

## Key facts

- **NCT ID:** NCT03570918
- **Lead sponsor:** MacroGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-25
- **Primary completion:** 2021-09-28
- **Final completion:** 2021-09-28
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03570918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03570918, "MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03570918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*